Related references
Note: Only part of the references are listed.Influence of CYP2C8 and CYP2C9 polymorphisms on pharmacokinetic and pharmacodynamic parameters of racemic and enantiomeric forms of ibuprofen in healthy volunteers
Rosario Lopez-Rodriguez et al.
PHARMACOLOGICAL RESEARCH (2008)
Enantioselective CE method for pharmacokinetic studies on ibuprofen and its chiral metabolites with reference to genetic polymorphism
Franciszek Glowka et al.
ELECTROPHORESIS (2007)
CYP2C8 polymorphism among the Portuguese
I Cavaco et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2006)
Interethnic and intraethnic variability of CYP2C8 and CYP2C9 polymorphisms in healthy individuals
Elena Garcia-Martin et al.
MOLECULAR DIAGNOSIS & THERAPY (2006)
Enantioselective pharmacokinetics of ibuprofen and involved mechanisms
HP Hao et al.
DRUG METABOLISM REVIEWS (2005)
The effect of the cytochrome P450CYP2C8 polymorphism on the disposition of (R)-ibuprofen enantiomer in healthy subjects
C Martinez et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Cytochrome P450 2C9 phenotyping using low-dose tolbutamide
A Jetter et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Interindividual variability in ibuprofen pharmacokinetics is related to interaction of cytochrome P4502C8 and 2C9 amino acid polymorphisms
E García-Martín et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Genetic predisposition to acute gastrointestinal bleeding after NSAIDs use
C Martinez et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Enantioselective determination of ibuprofen in plasma by high-performance liquid chromatography-electrospray mass spectrometry
PS Bonato et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2003)
Polymorphism in CΥP2C8 is associated with reduced plasma concentrations of repaglinide
M Niemi et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
Acenocoumarol pharmacokinetics in relation to cytochrome P4502C9 genotype
HHW Thijssen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
Genetic polymorphisms of CYP2C8 in Japanese population
M Nakajima et al.
DRUG METABOLISM AND DISPOSITION (2003)
CYP2C8 polymorphisms in Caucasians and their relationship with paclitaxel 6α-hydroxylase activity in human liver microsomes
N Bahadur et al.
BIOCHEMICAL PHARMACOLOGY (2002)
Linkage between the CYP2C8 and CYP2C9 genetic polymorphisms
U Yasar et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Stereoselectivity of ibuprofen metabolism and pharmacokinetics following the administration of the racemate to healthy volunteers
SC Tan et al.
XENOBIOTICA (2002)
Enantiospecific effects of cytochrome P4502C9 amino acid variants on ibuprofen pharmacokinetics and on the inhibition of cyclooxygenases 1 and 2
J Kirchheiner et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2002)
Impact of CYP2C9 amino acid polymorphisms on glyburide kinetics and on the insulin and glucose response in healthy volunteers
J Kirchheiner et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2002)
Identification of a null allele of CYP2C9 in an African-American exhibiting toxicity to phenytoin
RS Kidd et al.
PHARMACOGENETICS (2001)
Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid
D Dai et al.
PHARMACOGENETICS (2001)
Polymorphism of the cytochrome P450 (CYP) 2C9 gene in Japanese epileptic patients:: genetic analysis of the CYP2C9 locus
J Imai et al.
PHARMACOGENETICS (2000)
Share Paper
